DNA methylation inhibits p53-mediated survivin repression

Oncogene

Volumn 28, Issue 19, 2009, Pages 2046-2050

  Nabilsi, N H ^a   Broaddus, R R ^b   Loose, D S ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Cancer; DNA methylation; Endometrium

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA; PROTEIN P53; SURVIVIN; AZACITIDINE; BIRC5 PROTEIN, HUMAN; DRUG DERIVATIVE; MICROTUBULE ASSOCIATED PROTEIN;

ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; ENDOMETRIUM CANCER; FEMALE; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; TUMOR SUPPRESSOR GENE; DRUG EFFECT; ENDOMETRIUM TUMOR; GENETICS; METABOLISM; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AZACITIDINE; DNA METHYLATION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 66149100139     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.62     Document Type: Article

References (26)

1. Ambrosini G, Adida C, Altieri DC.(1997).A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-921.
2. Ambrosini G, Adida C, Sirugo G, Altieri DC.(1998).Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 273: 11177-11182.
3. Campanero MR, Armstrong MI, Flemington EK.(2000).CpG methylation as a mechanism for the regulation of E2F activity. Proc Natl Acad Sci USA 97: 6481-6486.
4. Erkanli S, Bolat F, Kayaselcuk F, Demirhan B, Kuscu E.(2007). COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma. Gynecol Oncol 104: 320-325.
5. Erkanli S, Kayaselcuk F, Kuscu E, Bagis T, Bolat F, Haberal A et al. (2006).Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium. Int J Gynecol Cancer 16: 1412-1418.
6. Esteve PO, Chin HG, Pradhan S.(2005).Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters. Proc Natl Acad Sci USA 102: 1000-1005.
7. Fukuda S, Pelus LM.(2006).Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 5: 1087-1098.
8. Furlan D, Carnevali I, Marcomini B, Cerutti R, Dainese E, Capella C et al.(2006).The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas. Clin Cancer Res 12: 3329-3336.
9. Hattori M, Sakamoto H, Satoh K, Yamamoto T.(2001).DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes. Cancer Lett 169: 155-164.
10. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M.(2002). Transcriptional repression of the anti-apoptotic survivin gene by wild type p5. J Biol Chem 277: 3247-3257.
11. Hopfer O, Komor M, Koehler IS, Schulze M, Hoelzer D, Thiel E et al. (2007).DNA methylation profiling of myelodysplastic syndrome hematopoietic progenitor cells during in vitro lineage-specific differentiation. Exp Hematol 35: 712-723.
12. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al.(2008). Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
13. Konno R, Yamakawa H, Utsunomiya H, Ito K, Sato S, Yajima A. (2000).Expression of survivin and Bcl-2 in the normal human endometrium. Mol Hum Reprod 6: 529-534.
14. Lehner R, Enomoto T, McGregor JA, Shroyer L, Haugen BR, Pugazhenthi U et al.(2002).Correlation of survivin mRNA detection with histologic diagnosis in normal endometrium and endometrial carcinom. Acta Obstet Gynecol Scand 81: 162-167.
15. Li F, Altieri DC.(1999).Transcriptional analysis of human survivin gene expression. Biochem J 344(Part 2): 305-311.
16. Meng RD, Phillips P, El-Deiry WS.(1999).p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin. Int J Oncol 14: 5-14.
17. Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, Black S et al.(2002).Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Onco-gene 21: 2613-2622.
18. Prat J, Gallardo A, Cuatrecasas M, Catasus L.(2007).Endometrial carcinoma: pathology and genetics. Pathology 39: 72-87.
19. Renaud S, Loukinov D, Abdullaev Z, Guilleret I, Bosman FT, Lobanenkov V et al.(2007).Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene. Nucleic Acids Res 35: 1245-1256.
20. Renaud S, Loukinov D, Bosman FT, Lobanenkov V, Benhattar J. (2005).CTCF binds the proximal exonic region of hTERT and inhibits its transcription. Nucleic Acids Res 33: 6850-6860.
21. Shang Y.(2006).Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. Nat Rev Cancer 6: 360-368.
22. Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I.(2002). Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma. Cancer Lett 184: 105-116.
23. Wu H, Chen Y, Liang J, Shi B, Wu G, Zhang Y et al.(2005). Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature 438: 981-987.
24. Xie R, Loose DS, Shipley GL, Xie S, Bassett Jr RL, Broaddus RR. (2007).Hypomethylation-induced expression of S100A4 in endo-metrial carcinoma. Mod Pathol 20: 1045-1054.
25. Yoshida H, Broaddus R, Cheng W, Xie S, Naora H.(2006). Deregulation of the HOXA10 homeobox gene in endometrial carcinoma: role in epithelial- mesenchymal transition. Cancer Res 66: 889-897.
26. Zhou XC, Dowdy SC, Podratz KC, Jiang SW.(2007).Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment. Gynecol Oncol 107: 143-153.